Hypothesis:Increasingly, gastroesophageal reflux disease (GERD) is suggested to cause laryngeal signs and symptoms,1often referred to as laryngopharyngeal reflux(LPR). But can LPR still be said to exist in a patient who is unresponsive to aggressive therapy? What should we tell the group of patients whose symptoms or laryngeal signs do not improve under acid-suppressive therapy? Here are a few selected answers from my “learned” colleagues: (1) Patients' symptoms are most definitively still caused by LPR, and lack of response to acid suppression does not rule out reflux as the cause. (2) Intermittent acid reflux may still occur in this group causing patients' findings. (3) Acid is truly not the culprit, and pepsin is the main agent responsible. And (4) Surgical fundoplication should be attempted in the patients who do not respond to therapy. All of these suggestions assume that reflux is the symptoms' cause and never question whether the LPR diagnosis was incorrect in the first place. Should we continue to insist on reflux as the diagnosis just because we may not know what else might be the cause of patients' persistent symptom complex? I would argue that this is not good clinical care.
Michael F. Vaezi, MD, PhD, MSc (Epi)
Thank you for submitting a comment on this article. It will be reviewed by JAMA Otolaryngology–Head & Neck Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Figure 22.1-2. Cost-effectiveness Plane and Sensitivity Analysis on Price of H2RAs
Figure 22.1-3. Probabilistic Sensitivity Analysis and Cost-effectiveness Acceptability Curves...
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.